Skip to main content

Table 1 Baseline characteristics of the patients

From: Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

 

No therapy (n = 57)

Patients receiving any therapie (n = 436)

Patients with systemic therapy (n = 352)

Patients with local therapy only (n = 84)

Age at diagnosis (years)

        

Median

72

 

62

 

62

 

65

 

Range

50-84

 

34-86

 

34-86

 

44-85

 

< 70 years

22

(38.6)

321

(73.6)

261

(74.1)

60

(71.4)

≥ 70 years

35

(61.4)

115

(26.4)

91

(25.9)

24

(28.6)

Sex

        

Male

46

(80.7)

299

(68.6)

237

(67.3)

62

(73.8)

Female

11

(19.3)

137

(31.4)

115

(32.7)

22

(26.2)

Smoking status

        

Neversmoker

2

(4.8)

35

(9.9)

35

(12.5)

0

(0)

Former smoker

25

(59.5)

143

(40.5)

115

(40.9)

28

(38.9)

Current smoker

15

(35.7)

175

(49.6)

131

(46.6)

44

(61.1)

Unknown

15

 

83

 

71

 

12

 

Stage

        

Stage IV, UICC 6. edition

57

100

436

(100)

352

(100)

84

(100)

Stage IV, UICC 7. edition

56

(98.2)

419

(96.1)

338

(96.0)

81

(96.4)

Stage IIIB, UICC 7. edition

1

(1.8)

17

(3.9)

14

( 4.0)

3

(3.6)

Histology

        

Adenocarcinoma

25

(43.9)

255

(58.5)

222

(63.1)

33

(39.3)

Squamous cell carcinoma

18

(31.6)

85

(19.5)

56

(15.9)

29

(34.5)

Large cell undifferentiated carcinoma

14

(24.6)

96

(22.0)

74

(21.0)

22

(26.2)

  1. Percentages are displayed in brackets. Stage classification according to either 6th or 7th UICC edition. Because of rounding, not all percentages sum to 100.